178
Participants
Start Date
December 8, 2023
Primary Completion Date
November 20, 2026
Study Completion Date
July 20, 2027
LBL-024 for Injection
Initial dose-MTD; Q3W; intravenous infusion
Etoposide Injection
Initial dose（Dose was decided by the investigator according to the subject's condition）; Q3W; intravenous infusion
Carboplatin Injection
Initial dose（Dose was decided by the investigator according to the subject's condition）; Q3W; intravenous infusion
Atezolizumab injection
Initial dose; Q3W; intravenous infusion
Cisplatin injection
Initial dose（Dose was decided by the investigator according to the subject's condition）; Q3W; intravenous infusion
RECRUITING
Beijing GoBroad Hospital, Beijing
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Liaoning Cancer Hospital, Shenyang
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
Fudan University Shanghai Cancer Center, Shanghai
RECRUITING
Anhui Provincial Hospital, Hefei
RECRUITING
Anhui Cancer Hospital, Hefei
RECRUITING
Qilu Hospital of Shandong University, Jinan
RECRUITING
Shandong Cancer Hospital, Jinan
RECRUITING
The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
RECRUITING
The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
RECRUITING
Sir Run Run Shaw Hospital，Zhejiang University School of Medicine, Hangzhou
RECRUITING
Zhejiang Cancer Hospital, Hangzhou
RECRUITING
The First Affiliated Hospital of Nanchang University, Nanchang
RECRUITING
Fujian Cancer Hospital, Fuzhou
RECRUITING
Chongqing University Cancer Hospital, Chongqing
RECRUITING
Hubei Cancer Hospital, Wuhan
RECRUITING
Xiangyang Central Hospital, Xiangyang
RECRUITING
Henan Cancer Hospital, Zhengzhou
RECRUITING
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang
RECRUITING
The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou
RECRUITING
Guangxi Medical University Cancer Hospital, Nanning
RECRUITING
West China Hospital of Sichuan University, Chengdu
RECRUITING
Shanxi Cancer hospital, Taiyuan
Nanjing Leads Biolabs Co.,Ltd
INDUSTRY